Cold Plasma Market Size, Share and Trends 2026 to 2035

What is the Cold Plasma Market Size?

The global cold plasma market size is valued at USD 3.28 billion in 2025 and is predicted to increase from USD 3.75 billion in 2026 to approximately USD 12.19 billion by 2035, expanding at a CAGR of 14.03% from 2026 to 2035. The increasing implementation of cold plasma into various chronic disease treatments is driving the growth of the market.

Cold Plasma Market Key Takeaways

• The global cold plasma market was valued at USD 3.28 billion in 2025.
• It is projected to reach USD 12.19 billion by 2035.
• The cold plasma market is expected to grow at a CAGR of 14.03% from 2026 to 2035.
• North America led the cold plasma market and contributed more than 41% of the market share in 2025.
• Asia Pacific is projected to grow at the fastest CAGR of 16.82% during the forecast period.
• By pressure, the atmospheric pressure cold plasma segment accounted for the highest market share of 66% in 2025.
• By pressure, the low-pressure cold plasma segment is growing at a notable CAGR of 17.02% over the forecast period.
• By application, the wound healing application segment generated the largest market share of 32% in 2025.
• By application, the cancer treatment application segment is projected to grow at a solid CAGR of 17.02% during the predicted period.

Market Overview

Cold plasma is a fully or partially ionized gas that can be used in a wide range of industrial applications. The cold plasma is also known as the non-equilibrium plasma. In it, the electrons are at higher temperatures, and neutron atoms are at lower temperatures. Cold plasma is used in different industrial sectors such as wastewater management, medical science, healthcare, agriculture, and others.

What is the use of AI in the cold plasma industry?

The integration of artificial intelligence into medicine creates the latest opportunities in the early treatment and diagnosis of disease. The integration of AI significantly improves and revolutionizes the field of plasma medicine. The increasing adoption of cold atmospheric plasma in different medicines and treatments. The use of AI in plasma medicine improves efficiency by analyzing large amounts of data, predicting treatment results, and increasing treatment protocol with enhanced precision.

• In September 2023, US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced cutting-edge achievements in robotic and surgical technology. The Canady Robotic AI Surgical System is a one-of-a-kind AI robotic system that delivers cold atmospheric plasma (CAP).

Cold Plasma Market Growth Factors

• Industrial usage: Cold plasma is highly used by several leading end-use industries, and it is used in industrial processes, including plasma-assisted chemical vapour deposition (PACVD) and plasma etching.
• Rising demand from the healthcare industry: The rising demand for cold plasma from the healthcare industry for increasing patient treatment procedures and advanced technologies with non-invasive and safer medical processes is enhancing the demand from the cold plasma market.
• Associated benefits: Cold plasma provides several benefits in different sectors and applications, including its use in medicines, such as the treatment of various chronic diseases and types of wound healing. Further, it is used in food, material science, wastewater treatment, skin rejuvenation, micro-coating, and others that boost the demand for cold plasma.
• Rising environmental awareness: The rising concern about environmental pollution caused by the harmful chemicals that are used in industrial operations, which create adverse effects on the environmental health of living beings and drive the demand for eco-friendly alternatives to those chemicals, is accelerating the growth of the cold plasma market.

Cold Plasma Market Outlook

• Industry Growth Overview: Between 2025 and 2030, this market is expected to rise significantly due to the rising incidences of cancer in different parts of the world coupled with technological advancements in the healthcare sector.
• Major Investors: Numerous cold plasma brands are actively entering this market, drawn by partnerships, R&D and business expansions. Several market players such as Bovie Medical Corporation, Neoplas Med GmbH, Europlasma NV and some others have started investing rapidly for providing cold plasma across the world.
• Startup Ecosystem: Various startup companies are engaged in developing cold plasma. The prominent startup brands dealing in cold plasma comprises of Coldray Plasma Labs, Clean Crop Technologies, Plasmacure and some others.

Market Scope

Market Dynamics

Driver

The increase in the use of cold plasma in various healthcare applications

The rising adoption of cold plasma in different healthcare applications owing to its benefits in treatment, including high precision and cost-effectiveness in treatment, is driving the growth of the cold plasma market. It is used in healthcare applications like wound healing and prevention of skin diseases; it is highly efficient in providing cost-efficient and accurate cancer treatment in oral and dental diseases, and it is effectively used in treating fungal nail infections and other types of infections. Additionally, the rising investment in innovations and the launch of drugs and treatment procedures for chronic disease treatment accelerate the growth of the market.

• In June 2023, Adtec Healthcare Limited, the original subsidiary of the parent company Adtec Technology Japan, introduced Cold Plasma on wounds in clinical trials, which is the leading technology aiming to treat chronic and infected wounds having strong antibacterial properties with no side effects.

Restraint

Cost of implementation

The cost of installing cold plasma technology in industries is high due to its advanced and complex equipment, and the increased consumption of gas makes it expensive in nature, which limits the expansion of the cold plasma market.

Opportunity

Use of cold plasma in food processing

Cold plasma is an emerging technology that helps improve the overall efficiency of various industrial operations. It is a proven non-thermal technology that is broadly used in the agriculture and food processing industry and helps in improving safety and efficiency. The cold plasma technology in enzyme denaturation, microbial decontamination, pesticide degradation, polyphenols, food allergens, food packaging, and various other physiological processes involved in food processing.

Segment Insights

Pressure Insights

The atmospheric pressure cold plasma segment dominated the cold plasma market in 2025. The increasing adoption of atmospheric pressure cold plasma by several leading industries such as material science, food and medical industry, surface treatment, and agriculture industry. It is the most cost-efficient technology that can be generated at atmospheric pressure and low temperature using different techniques and gases. The atmospheric pressure cold plasma is highly used in the food industry for modifying and extracting food and nutrients and processing food waste. The implementation of the atmospheric pressure cold plasma in the agriculture industry helps increase the length of the root and germination rates. It is highly environment friendly. It helps in degrading pollutants and is used in water and air purification.

The low-pressure cold plasma segment is predicted to witness significant growth in the cold plasma market over the forecast period. The low-pressure cold plasma is a non-thermal plasma made by using an electromagnetic field with a low-pressure space and utilizing chemically active gases. The low-pressure cold plasma is used in different applications like the food industry, textile industry, material processing, and plastic industry. The low-pressure cold plasma is a highly environment-friendly, chemical-free, and cost-effective solution that is used in different end-use industries.

Application Insights

The wound healing application segment registered its dominance over the cold plasma market in 2025. Cold plasma is one of the latest technologies or processes used in wound healing. The cold plasma consists of the reactive oxygen and nitrogen species, which are controlled by several factors, including gas flow rate, composition, voltage, frequency, power, and exposure time; it can be used against the inactivation or destruction of bacterial infection and increase the wound healing process. The reactive species that are present in the cold plasma damages the intracellular components and cell membrane, which destroys bacterial cells. The cold plasma increases the process of wound healing by activating macrophages, neutrophils, endothelial cells, fibroblasts, and keratinocytes. Cold plasma maintains the initiating angiogenesis, tissue oxygenation, and collagen synthesis that promotes rapid wound healing.

The cancer treatment application segment is expected to grow at the fastest rate in the cold plasma market during the predicted period. The rising cases of different types of cancer worldwide cause the demand for efficient and cost-effective treatment for it. The integration of the cold atmospheric plasma in the cancer provides efficient treatment with better precision. The cold atmospheric plasma used the ionized gas to kill the cancer cells. It is one of the rapid and reliable treatments for cancer; its cost efficiency and no side effects on the healthy cells of the body make it one of the promising treatments for cancer patients. Cold atmospheric plasma is used in various cancer treatments, including glioblastoma, breast cancer, melanoma, cervical cancer, and prostate cancer.

Regional Insights

What is the U.S. Cold Plasma Market Size?

The U.S. cold plasma market size is evaluated at USD 1,080 million in 2025 and is projected to be worth around USD 4,087 million by 2035, growing at a CAGR of 14.23% from 2026 to 2035.

North America dominated the cold plasma market in 2025. The growth of the market is attributed to the rising healthcare infrastructure and the integration of technologies in it. The rising industrial infrastructure and technological advancements in the industries are driving the growth of the market. Additionally, the rising chronic illness in the population and the expenditure on healthcare, sterilization, and treatment methods. Increasing cancer cases in the United States are driving the demand for cold plasma for the treatment of the disease. The rising availability of the leading healthcare technologies and medical firms is collectively accelerating the growth of the cold plasma market in the region.

• The latest estimation of the new invasive cancer cases in the United States is 1,958,310 as per sex and cancer type, which is equivalent to about 5370 cases each day.
• It is recorded that there were about 609,820 mortality by cancer in the United States in 2023, which is equivalent to 1670 deaths per day.

U.S. Market Trends

The U.S. market is characterized by a high level of medical adoption, especially in chronic wound healing or dermatology. Growing FDA approvals endorse surgical applications. Cold plasma is used in high-end applications in semiconductor fabrication to treat surfaces with high precision. It is, free of contaminants, reinforcing its stance in health and high-technology industrial markets.

Asia Pacific expects the fastest growth in the market during the forecast period. The growth of the market is owing to the rising population and the increasing demand for industrial development in the countries and further technical advancement. The rising geriatric population is driving the demand for efficient treatment procedures, and the evaluation of healthcare technologies is collectively boosting the growth of the cold plasma market across the region.

• The estimated number of cancer patients in India was 1,461,427 in 2022, with lung cancer ranked highest in men and breast cancer in women. There is a 12.8% expected increase in cancer cases by 2025 as compared to 2020.

China Market Trends

China leads with a high application of cold plasma in electronics and semiconductor production to clean and coat products. There is growing adoption in food safety towards the sterilization of frozen products. The intensive investment in local manufacturing capacity contributes to growth in automotive, polymer, and high-technology industrial applications.

What led Europe to hold a significant share of the cold plasma market?

Europe held a significant share of the market. The growing cases of road accidents in numerous countries such as Germany, Italy, France, UK and some others has boosted the market expansion. Additionally, rapid investment by government for strengthening the healthcare sector is expected to propel the growth of the cold plasma market in this region.

Germany Market Trends

Germany is at the forefront of cold plasma integration with automated sterilization and industrial processing production systems. High sustainability is a motivating factor towards its use as a chemical-free replacement as part of the REACH requirements. There is also a high level of development in medical research in the region, especially on antimicrobial treatments and dermatological applications through plasma technologies.

What made Latin America to hold a considerable share of the cold plasma market?

Latin America held a considerable share of the industry. The rising incidences of blood cancer in various nations including Brazil, Argentina, Peru, Venezuela and some others has driven the market growth. Also, technological advancements in modern hospitals coupled with rapid expansion of the healthcare sector is expected to accelerate the growth of the cold plasma market in this region.

Brazil Market Trends

The market in Brazil is growing as people are increasingly using cold plasma as a method of wound management and surgery. There is increased research interest in applications of cancer therapy. One of the aspects of the digital transformation that industrial sectors pursue is the adoption of improved automation and efficiency in manufacturing through the use of advanced plasma technologies.

How did Middle East and Africa held a notable share of the cold plasma market?

Middle East and Africa held a notable share of the market. The increasing focus of the healthcare companies to develop high-quality therapies for patients suffering from blood-related issues has boosted the market expansion. Additionally, rapid investment by market players for opening up new research and development centers is expected to foster the growth of the cold plasma market in this region.

Saudi Arabia Market Trends

The application of cold plasma as a medical process of sterilization in healthcare and aesthetic dermatology in Saudi Arabia is being adopted. It is used in the surface treatment process in industrial modernization under Vision 2030. The trend towards chemical-free solutions and sophisticated sterilization technology is gaining acceptance in the healthcare and manufacturing industries.

Cold Plasma Market Companies

• Apyx Medical : Apyx Medical is an advanced energy technology company that develops and manufactures medical devices for both cosmetic and hospital surgical applications. It operates through two segments such as Advanced Energy, which includes its Renuvion and J-Plasma systems, and Original Equipment Manufacturing (OEM).
• Adtec Healthcare Limited: Adtec Healthcare Limited is a UK-based medical device company specializing in the development and manufacture of the SteriPlas medical device, which uses low-energy microwave-powered cold plasma for infection management. It is a topical antibacterial treatment for chronic wounds and antimicrobial-resistant infections, with applications in wound care, dermatology, and surgical site infection control.
• Bovie Medical Corporation: Bovie Medical Corporation is an energy-based medical device company that develops, manufactures, and markets electrosurgical products and technologies for use in healthcare settings. The company is known for its electrosurgical generators, electrodes, and pencils, as well as other specialty products like battery-operated cauteries and nerve locators.
• Neoplas Med GmbH: Neoplas Med GmbH is a German medical technology company founded in 2009 as a spin-off of the Leibniz Institute for Plasma Science and Technology (INP) in Greifswald. It specializes in developing and manufacturing innovative cold plasma jet technology for medical applications, particularly for treating chronic wounds and pathogen-related skin diseases.
• Europlasma NV: Europlasma NV is a Belgian company that is a global leader in low-pressure plasma technology, specializing in creating ultra-thin nano-coatings. This company designs and builds turnkey vacuum plasma treatment equipment, develops proprietary processes, and supplies process chemicals for applications in electronics, textiles, medical devices, and filtration
• P2i Ltd.: P2i Ltd is a nanotechnology company that develops and provides ultra-thin plasma coatings to make products, especially electronics, liquid-repellent and more durable. This company serves various markets globally, including electronics, life sciences, and filtration.
• US Medical Innovations :US Medical Innovations, LLC (USMI) is a medical device manufacturer that specializes in plasma-based technologies for minimally invasive cancer treatments and other medical applications. This brand is a pioneer in plasma medicine, developing advanced medical devices with a primary focus on treating solid tumors.

Other Major Key Players

• terraplasma medical GmbH
• CINOGY System GmbH

Segments Covered in the Report

By Pressure

• Low-Pressure Cold Plasma
• Atmospheric Pressure Cold Plasma

By Application

• Wound Healing
• Blood Coagulation
• Dentistry
• Cancer Treatment
• Other Medical Applications

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa